GLYCATION PRODUCT FORMATION INHIBITOR AND PHARMACEUTICAL COMPOSITION

To provide a glycation product formation inhibitor capable of inhibiting formation of glycation products.SOLUTION: The glycation product formation inhibitor contains, as an active ingredient, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. In the formula, Ar...

Full description

Saved in:
Bibliographic Details
Main Authors ONO KAZUHIKO, NAKAJIMA MANABU
Format Patent
LanguageEnglish
Japanese
Published 22.02.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide a glycation product formation inhibitor capable of inhibiting formation of glycation products.SOLUTION: The glycation product formation inhibitor contains, as an active ingredient, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. In the formula, Ar represents an aryl group; R1 represents a hydrogen atom or alkyl group; n represents an integer from 1 to 3; and m represents an integer from 1 to 4.SELECTED DRAWING: Figure 5 【課題】糖化産物の生成を抑制可能な糖化産物生成抑制剤を提供する。【解決手段】式（１）で表される化合物又はその薬学的に許容される塩を有効成分として含む糖化産物生成抑制剤である。式中、Ａｒはアリール基を表し、Ｒ１は水素原子又はアルキル基を表し、ｎは１から３の整数、ｍは１から４の整数を表す。【選択図】図５
Bibliography:Application Number: JP20190144724